4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,080.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,120.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 739
  • Market Cap: £138.30m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,252,453 £13,526,492
Joseph Manuel Fernández 448,244 £4,841,035
David John Roth 316,000 £3,412,800
Maria Del Pilar de la Huerta 6,667 £72,004
Hansjörg Plaggemars 6,667 £72,004
Timothy Paul McCarthy 2,388 £25,790

Major Shareholders

Notifier** Holding Value*
DELPHI Unternehmensberatung AG 6,604,357 £71,327,056
Wilhelm K. T. Zours 6,604,357 £71,327,056
Deutsche Balaton AG 5,965,921 £64,431,947
4bb AG 3,665,242 £39,584,614
2invest AG 3,665,242 £39,584,614
Sparta AG 1,351,718 £14,598,554

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,080.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,120.00
52 Week Low 500.00
Volume 739
Shares Issued 12.81m
Market Cap £138.30m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
98.04% above the market average98.04% above the market average98.04% above the market average98.04% above the market average98.04% above the market average
96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average
Income Not Available
Growth
35.04% below the market average35.04% below the market average35.04% below the market average35.04% below the market average35.04% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

4basebio Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
14:25 182 @ 1,096.00p
13:48 500 @ 1,061.00p
12:07 57 @ 1,096.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page